<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Vestnik dermatologii i venerologii</journal-id><journal-title-group><journal-title xml:lang="en">Vestnik dermatologii i venerologii</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник дерматологии и венерологии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0042-4609</issn><issn publication-format="electronic">2313-6294</issn><publisher><publisher-name xml:lang="en">Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">5</article-id><article-id pub-id-type="doi">10.25208/0042-4609-2014-90-1-30-36</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>ORIGINAL STUDIES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>НАУЧНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Level of the proliferative activity of lymphocytes in case of mycosis fungoides and plaque parapsoriasis</article-title><trans-title-group xml:lang="ru"><trans-title>Уровень пролиферативной активности лимфоцитов при грибовидном микозе и бляшечном парапсориазе</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Zhukov</surname><given-names>A. S.</given-names></name><name xml:lang="ru"><surname>Жуков</surname><given-names>А. С.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>md.zhukov@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Belousova</surname><given-names>I. E.</given-names></name><name xml:lang="ru"><surname>Белоусова</surname><given-names>И. Э.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Khairutdinov</surname><given-names>V. R.</given-names></name><name xml:lang="ru"><surname>Хайрутдинов</surname><given-names>В. Р.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Telichko</surname><given-names>I. N.</given-names></name><name xml:lang="ru"><surname>Теличко</surname><given-names>И. Н.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Samtsov</surname><given-names>A. V.</given-names></name><name xml:lang="ru"><surname>Самцов</surname><given-names>А. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Military Medical Academy named after S.M. Kirov Ministry of Defense of the Russian Federation Akademika</institution></aff><aff><institution xml:lang="ru">ФГБВОУ ВПО «Военно-медицинская академия им. С.М. Кирова» МО РФ</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2014-02-24" publication-format="electronic"><day>24</day><month>02</month><year>2014</year></pub-date><volume>90</volume><issue>1</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>30</fpage><lpage>36</lpage><history><date date-type="received" iso-8601-date="2017-08-24"><day>24</day><month>08</month><year>2017</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2014, Zhukov A.S., Belousova I.E., Khairutdinov V.R., Telichko I.N., Samtsov A.V.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2014, Жуков А.С., Белоусова И.Э., Хайрутдинов В.Р., Теличко И.Н., Самцов А.В.</copyright-statement><copyright-year>2014</copyright-year><copyright-holder xml:lang="en">Zhukov A.S., Belousova I.E., Khairutdinov V.R., Telichko I.N., Samtsov A.V.</copyright-holder><copyright-holder xml:lang="ru">Жуков А.С., Белоусова И.Э., Хайрутдинов В.Р., Теличко И.Н., Самцов А.В.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://vestnikdv.ru/jour/article/view/5">https://vestnikdv.ru/jour/article/view/5</self-uri><abstract xml:lang="en"><p>The level of the proliferative activity is an important predictor of a number of oncologic diseases; at the same time, its diagnostic value for mycosis fungoides was not adequately investigated. Goal. To study the proliferative activity of lymphocytes in the skin of patients suffering form mycosis fungoides and plaque parapsoriasis. Materials and methods. The level of CD3+ and Ki-67+ cells was determined in skin biopsy samples taken from patients suffering from mycosis fungoides (18 subjects) and plaque parapsoriasis (6 subjects) by means of immunohistochemistry. The epidermal to dermal skin cell proliferative activity ratio (Ki-67+) and cell proliferative activity index were calculated. The control group comprised 16 healthy people. Results. The epidermal to dermal skin cell proliferative activity ratio amounted to 10.9 in healthy people, 5.43 in patients suffering from plaque parapsoriasis, and 3.84 and 2.42 in patients suffering from mycosis fungoides, spotty and plaque and tumor stages, respectively. The percentage of proliferative CD3+Ki-67+ cells relative to the total number of T-lymphocytes amounted to 1% in the patients suffering from plaque parapsoriasis and 3% in the patients with mycosis fungoides, spotty stage. Conclusion. The epidermal to dermal skin cell proliferative activity ratio (Ki-67+) in patients suffering from mycosis fungoides at any stage is lower than that in healthy subjects and patients suffering from parapsoriasis. The cell proliferative activity index was higher in the patients with mycosis fungoides, plaque and tumor stage, than in the patients with parapsoriasis. The number of CD3+Ki-67+ cells was higher in the patients with mycosis fungoides, spotty and plaque and tumor stages, than in the healthy subjects and patients suffering from parapsoriasis.</p></abstract><trans-abstract xml:lang="ru"><p>Уровень пролиферативной активности является важным прогностическим фактором ряда онкологических заболеваний, но его диагностическая значимость при грибовидном микозе до настоящего времени изучена недостаточно. Цель. Изучение пролиферативной активности лимфоцитов в коже больных грибовидным микозом и бляшечным парапсориазом. Материал и методы. Методом иммуногистохимического исследования в биоптатах кожи больных грибовидным микозом (18 пациентов) и бляшечным парапсориазом (6 пациентов) определяли содержание CD3+ и Ki-67+ клеток. Рассчитывали коэффициент эпидермо-дермального отношения пролиферативной активности клеток (Ki-67+) кожи и индекс пролиферативной активности клеток. Группу контроля составили 16 здоровых лиц. Результаты. Коэффициент эпидермо-дермального отношения пролиферирующих клеток у здоровых людей составил 10,9, у больных бляшечным парапсориазом - 5,43, у пациентов с грибовидным микозом пятнистой и бляшечно-опухолевой стадий - 3,84 и 2,42 соответственно. Доля пролиферирующих CD3+Ki-67+ клеток от общего количества Т-лимфоцитов составила у больных бляшечным парапсориазом 1%, у пациентов с грибовидным микозом пятнистой стадии - 3%. Заключение. Коэффициент эпидермо-дермального отношения пролиферативной активности клеток (Ki-67+) кожи у больных грибовидным микозом всех стадий ниже, чем у здоровых людей и пациентов с парапсориазом. Индекс пролиферативной активности клеток у пациентов с грибовидным микозом бляшечно-опухолевой стадии выше, чем у больных бляшечным парапсориазом. Количество CD3+Ki-67+ клеток у больных грибовидным микозом пятнистой и бляшечно-опухолевой стадии выше, чем у здоровых лиц и пациентов с бляшечным парапсориазом.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>грибовидный микоз</kwd><kwd>Ki-67</kwd><kwd>пролиферативная активность</kwd><kwd>Т-клеточная лимфома кожи</kwd><kwd>mycosis fungoides</kwd><kwd>Ki-67</kwd><kwd>proliferative activity</kwd><kwd>T-cell skin lymphoma</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Лез-винская Е.М., Молочков В.А., Ларина Н.К. Состояние заболеваемости злокачественными лимфомами кожи в Московской области и пути совершенствования лечебно-диагностической помощи больным. Росс. журн. кож. и вен. бол. 2000; (4): 12-17.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Ackerman A.B. If small plaque (digitate) parapsoriasis is a cutaneous T-cell lymphoma, even an «abortive» one, it must be mycosis fungoides! Arch Dermatol 1996; 132: 562-566.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Willemze R., Jaffe E.S., Burg G. et al. WHOEORTC classification for cutaneous lymphomas. Blood 2005; 105: 3768-3785.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Бабиченко И.И., Ковязин В.А. Новые методы иммуногистохимической диагностики опухолевого роста: Учеб. пособие. М: РУДН, 2008; 109.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Golmohammadi R., Pejhan A. The prognostic value of the P53 protein and the Ki-67 marker in breast cancer patients. J Pak Med Assoc 2012; 62 (9): 871-875.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Foltyn W., Zajеçki W., Marek B. et al. The value of the Ki-67 proliferation marker as a prognostic factor in gastroenteropancreatic neuroendocrine tumours. Endokrynol Pol 2012; 63 (5): 362-366.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>He W.L., Li Y.H., Yang D.J. et al. Combined evaluation of centromere protein H and Ki-67 as prognostic biomarker for patients with gastric carcinoma. Eur J Surg Oncol. 2013; 39 (2): 141-149.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Jovanovich M.P., Jakovich L., Bogdanovich A. et al. Poor outcome in patients with diffuse large B-cell lymphoma is associated with high percentage of bcl-2 and Ki 67-positive tumor cells. Vojnosanit Pregl 2009; 66 (9): 738-743.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Dummer R., Michie S.A., Kell D. et al. Expression of bcl-2 protein and Ki-67 nuclear proliferation antigen in benign and malignant cutaneous T-cell infiltrates. J Cutan Pathol 1995; 22 (1): 11-17.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Gambichler T., Bischoff S., Bechara F.G. et al. Expression of proliferation markers and cell cycle regulators in T cell lymphoproliferative skin disorders. J Dermatol Sci 2008; 49 (2): 125-132.</mixed-citation></ref></ref-list></back></article>
